Citations

Clear

4799 citation(s) found for "Yu, Jennifer".

Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia
Giacopelli, Brian , Zhao, Qiuhong , Ruppert, Amy S. , Agyeman, Akwasi, Wu, Yue-Zhong, Gerber, Madelyn M., Rabe, Kari G. , Lu, Junyan , Rogers, Kerry A. , Brown, Jennifer R. , Rai, Kanti R., Keating, Michael J. , Rassenti, Laura Z., Shanafelt, Tait D. , Abruzzo, Lynne V. , Coombes, Kevin R. , Woyach, Jennifer A. , Byrd, John C. , Oakes, Christopher C. , Byrd, John C. , Chaffee, Kari G. , Lu, Junyan , Rogers, Kerry A , Kay, Neil E , Coombes, Kevin R , Shanafelt, Tait D , Weigel, Christoph , Wu, Yue-Zhong, Larson, Melissa C. , Blachly, James S. , Wierda, William G. , Rai, Kanti R., Kipps, Thomas J. , Zenz, Thorsten , Kay, Neil E. , Byrd, John C

Mayo Clinic

Blood | July 11, 2019 | Volume: 134 | Issue: 8 | Pages: 688-698

10.1182/blood.2019000490 | PMID 31292113 Get It

AbstractAlterations in global DNA methylation patterns are a major hallmark of cancer and represent attractive biomarkers for personalized risk stratification. Chronic lymphocytic leukemia (CLL) risk stratification studies typically focus on time to first treatment (TTFT), time to progression (TTP) after treatment, and overall survival (OS). Whereas TTFT risk stratification remains similar over time, TTP and OS have changed dramatically with the introduction of targeted therapies, such as the Bruton tyrosine kinase inhibitor ibrutinib. We have shown that genome-wide DNA methylation patterns in CLL are strongly associated with phenotypic differentiation and patient outcomes. Here, we developed a novel assay, termed methylation-iPLEX (Me-iPLEX), for high-throughput quantification of targeted panels of single cytosine guanine dinucleotides from multiple independent loci. Me-iPLEX was used to classify CLL samples into 1 of 3 known epigenetic subtypes (epitypes). We examined the impact of epitype in 1286 CLL patients from 4 independent cohorts representing a comprehensive view of CLL disease course and therapies. We found that epitype significantly predicted TTFT and OS among newly diagnosed CLL patients. Additionally, epitype predicted TTP and OS with 2 common CLL therapies: chemoimmunotherapy and ibrutinib. Epitype retained significance after stratifying by biologically related biomarkers, immunoglobulin heavy chain mutational status, and ZAP70 expression, as well as other common prognostic markers. Furthermore, among several biological traits enriched between epitypes, we found highly biased immunogenetic features, including IGLV3-21 usage in the poorly characterized intermediate-programmed CLL epitype. In summary, Me-iPLEX is an elegant method to assess epigenetic signatures, including robust classification of CLL epitypes that independently stratify patient risk at diagnosis and time of treatment.
Trial of Galcanezumab in Prevention of Episodic Cluster Headache
Goadsby, Peter J. , Leone, Massimo , Bardos, Jennifer, Oakes, Tina M. , Millen, Brian A. , Zhou, Chunmei, Dowsett, Sherie A. , Aurora, Sheena K. , Ahn, Andrew H. , Yang, Jyun-Yan, Conley, Robert R., Martinez, James M. , Bardos, Jennifer N, Goadsby, Peter J , Dodick, David W.

Mayo Clinic

New England Journal of Medicine | July 10, 2019 | Volume: 381 | Issue: 2 | Pages: 132-141

10.1056/nejmoa1813440 | PMID 31291515 Get It

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease
Steinhart, A. Hillary , Bressler, Brian , Khanna, Reena , Afif, Waqqas , Bitton, Alain , Borgaonkar, Mark , Chauhan, Usha, Halloran, Brendan P. , Jones, Jennifer , Kennedy, Erin , Meddings, Jonathan B., Plamondon, Sophie , Rosenfeld, Greg , Seow, Cynthia H. , Williams, Chadwick, Bernstein, Çharles N. , Panaccione, Remo , Marshall, John K. , Targownik, Laura E. , Leontiadis, Grigorios I. , Loftus, Edward V. , Moayyedi, Paul , Murthy, Sanjay K. , Schwartz, David A. , Bernstein, Charles Noah

Mayo Clinic

Journal of the Canadian Association of Gastroenterology | July 10, 2019 | Volume: 2 | Issue: 3 | Pages: e1-e34

10.1093/jcag/gwz019 | PMID 31294378 Get It

Abstract Background & Aims Crohn’s disease (CD) is a lifelong illness with substantial morbidity, although new therapies and treatment paradigms have been developed. We provide guidance for treatment of ambulatory patients with mild to severe active luminal CD. Methods We performed a systematic review to identify published studies of the management of CD. The quality of evidence and strength of recommendations were rated according to the Grading of Recommendation Assessment, Development and Evaluation (GRADE) approach. Statements were developed through an iterative online platform and then finalized and voted on by a group of specialists. Results The consensus includes 41 statements focused on 6 main drug classes: antibiotics, 5-aminosalicylate, corticosteroids, immunosuppressants, biologic therapies, and other therapies. The group suggested against the use of antibiotics or 5-aminosalicylate as induction or maintenance therapies. Corticosteroid therapies (including budesonide) can be used as induction, but not maintenance therapies. Among immunosuppressants, thiopurines should not be used for induction, but can be used for maintenance therapy for selected low-risk patients. Parenteral methotrexate was proposed for induction and maintenance therapy in patients with corticosteroid-dependent CD. Biologic agents, including tumor necrosis factor antagonists, vedolizumab, and ustekinumab, were recommended for patients failed by conventional induction therapies and as maintenance therapy. The consensus group was unable to clearly define the role of concomitant immunosuppressant therapies in initiation of treatment with a biologic agent. Conclusions Optimal management of CD requires careful patient assessment, acknowledgement of patient preferences, evidence-based use of existing therapies, and thorough assessment to define treatment success.
Modelling the relationships between haemoglobin oxygen affinity and the oxygen cascade in humans
Shepherd, John R. A. , Dominelli, Paolo B. , Roy, Tuhin K. , Secomb, Timothy W. , Hoyer, James D., Oliveira, Jennifer L. , Herrick, Jennifer L. , Roy, Tuhin K , Secomb, Timothy W , Joyner, Michael J.

Mayo Clinic

The Journal of Physiology | July 10, 2019 | Volume: 597 | Issue: 16 | Pages: 4193-4202

10.1113/jp277591 | PMID 31290158 Get It

Key points Haemoglobin affinity is an integral concept in exercise physiology that impacts oxygen uptake, delivery and consumption. How chronic alterations in haemoglobin affinity impact physiology is unknown. Using human haemoglobin variants, we demonstrate that the affinity of haemoglobin for oxygen is highly correlated with haemoglobin concentration. Using the Fick equation, we model how altered haemoglobin affinity and the associated haemoglobin concentration influences oxygen consumption at rest and during exercise via alterations in cardiac output and mixed‐venous . The combination of low oxygen affinity haemoglobin and reduced haemoglobin concentration seen in vivo may be unable to support oxygen uptake during moderate or heavy exercise. AbstractThe physiological implications, with regard to exercise, of altered haemoglobin affinity for oxygen are not fully understood. Data from the Mayo Clinic Laboratories database of rare human haemoglobin variants reveal a strong inverse correlation (r = −0.82) between blood haemoglobin concentration and P50, an index of oxygen affinity [Hb = −0.3135(P50) + 23.636]. In the present study, observed P50 values for high, normal and low oxygen‐affinity haemoglobin variants (13, 26 and 39 mmHg) and corresponding haemoglobin concentrations (19.5, 15.5 and 11.4 g dL−1 respectively) are used to model oxygen consumption as a fraction of delivery at rest ( = 0.25 L min−1, cardiac output = 5.70 L min−1) and during exercise ( = 2.75 L min−1, cardiac output = 18.9 l min−1). With high‐affinity haemoglobin, the model shows that normal levels of oxygen consumption can be achieved at rest and during exercise at the assumed cardiac output levels, with reduced oxygen extraction both at rest (16.8% high affinity vs. 21.7% normal) and during exercise (55.8% high affinity vs. 72.2% normal). With low‐affinity haemoglobin, which predicts low haemoglobin concentration, oxygen consumption at rest can be sustained with the assumed cardiac output, with increased oxygen extraction (31.1% low affinity vs. 21.7% normal). However, exercise at 2.75 l min−1 cannot be achieved with the assumed cardiac output, even with 100% oxygen extraction. In conclusion, the model indicates chronic alterations in P50 associate directly with Hb concentration, highlighting that human Hb variants can serve as ‘experiments of nature’ to address fundamental hypotheses on oxygen transport and exercise.
Factors Associated with Cigarette Use During Airmen’s First Year of Service in the United States Air Force
Little, Melissa A. , Ebbert, Jon O. , Krukowski, Rebecca A. , Halbert, Jennifer P. , Kalpinski, Maj Ryan, Talcott, G. Wayne , Klesges, Robert C. , Patten, Christi A.

Mayo Clinic

Military Medicine | July 9, 2019 | Volume: 185 | Issue: 1-2 | Pages: e212-e220

10.1093/milmed/usz155 | PMID 31287888 Get It

Abstract Introduction Despite declines of cigarette use in the civilian population, military personnel report alarmingly high rates of cigarette use. Enlisted Air Force recruits are required to remain tobacco-free for the first 12 weeks of training, and the majority express confidence they will not use tobacco after the ban; however, most previous smokers return to smoking and many nonsmokers initiate. Understanding the factors associated with cigarette-smoking initiation among non-users and re-initiation among former users is critical for the development of successful tobacco control efforts. Materials and Methods The current study examines predictors of cigarette smoking among a sample of 2,188 USAF personnel after their first year of service. Logistic regression analyses examined associations between baseline predictors and initiation and re-initiation of cigarette smoking at a one-year follow-up. Results Compared to never smokers at both time points, the strongest predictor of smoking initiation over the past 12 months was having owned cigarette-branded merchandise (OR 3.81, 95% CI 1.67, 8.71). Compared to former smokers who remained abstinent, the strongest predictor of re-initiation was intention to use tobacco (OR 2.08, 95% CI 1.53, 2.83). Compared to individuals who initiate, the strongest predictors of re-initiation were prior use of other tobacco products and tobacco use intentions (ORs range 1.85 to 4.63). Conclusions Multiple risk factors are associated with tobacco use. Given that Airmen are tobacco-free for the first 12 weeks of training, tobacco interventions during this period might be more effective. Our findings can be used to tailor interventions to prevent tobacco use in the U.S. military.
Pregnancy and Parenting During Cardiology Fellowship
Mwakyanjala, Edson J., Cowart, Jennifer B. , Blair, Janis E. , Maniaci, Michael J. , Hayes, Sharonne N.

Mayo Clinic

Journal of the American Heart Association | July 9, 2019 | Volume: 8 | Issue: 14 | Pages: No page available

10.1161/jaha.119.012137 | PMID 31286816 Get It

Background An increasing number of residents and fellows have children during training. However, little is known about the specific experience of cardiology fellows who become parents during training. Methods and Results A 66‐question Internet‐based survey about experiences of pregnancy during graduate medical training was administered between May 1 and July 15, 2013, to all trainees (N=1516) in the Mayo School of Graduate Medical Education across 3 academic sites. Questions explored the experiences of new mothers, fathers, and their fellow trainees. There were 644 survey respondents overall (response rate, 42%), and of 73 cardiovascular trainees, 29 (10 women [35%]) completed the survey. Of those surveyed, 59% reported having children. All trainee mothers reported making alterations to their training schedule due to pregnancy and maternity leave. Twenty percent of trainee fathers also reported changing their training because of their partner's pregnancy. Of trainees with children, 41% reported difficulty completing research because of pregnancy and childcare obligations. Nontrainee mothers were significantly more likely to breastfeed beyond 6 months compared with trainee mothers ( P =0.018). A perceived stigma attached to pregnancy was reported by 62% of trainees. Both male and female trainees felt that their programs did not promote pregnancy‐related schedule flexibility. Conclusions Our study shows that both men and women entering parenthood during cardiology training often have to change their schedule, research, and career path. Cardiology training programs should focus on curriculum design and supportive parenthood policies to both avoid negative stigma and optimize fellowship training during this time period.
Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections
McDonald, Jennifer S. , Kolbe, Amy B. , Schmitz, John J. , Hartman, Robert P. , Kallmes, David F. , McDonald, Robert J. , Hunt, Christopher H , Schmitz, John J , Maddox, Daniel E. , Kallmes, David F , Hunt, Christopher H.

Mayo Clinic

Radiology | July 2, 2019 | Volume: 292 | Issue: 3 | Pages: 620-627

10.1148/radiol.2019182834 | PMID 31264948 Get It

Low-Pressure Lumbar Provocation Discography According to Spine Intervention Society/International Association for the Study of Pain Standards Does Not Cause Acceleration of Disc Degeneration in Patients With Symptomatic Low Back Pain
McCormick, Zachary L. , Plastaras, Christopher T. , Walega, David R., Huddleston, P.M. , Moussallem, Charbel D. , Geske, Jennifer R. , Verdoorn, Jared T. , Maus, Timothy P. , Lehman, Vance T. , Huddleston, Paul, Moussallem, Charbel, Carr, Carrie M. , Kennedy, David J. , Geske, Jennifer , Huddleston, Paul M

Mayo Clinic

Spine | July 1, 2019 | Volume: 44 | Issue: 19 | Pages: E1161-E1168

10.1097/brs.0000000000003085 | PMID 31261283 Get It

Study Design. Retrospective matched cohort study. Objective. To determine if low-pressure lumbar provocation discography (PD) results in long-term accelerated disc degeneration, internal disc disruption, or disc herniation in patients with symptomatic low back pain (LBP). Summary of Background Data. Study of subjects without clinically-significant LBP suggests that high-pressure PD may accelerate disc degeneration. Methods. Consecutive patients with symptomatic LBP who underwent magnetic resonance imaging (MRI), PD, and repeat MRI more than 7 years later, but did not undergo subsequent spinal fusion surgery, were included. Punctured discs were matched (1:2 to 1:4) to corresponding discs in a control cohort by age, BMI, Pfirrmann score (±2), and presence of disc herniation; control cohort inclusion required MRIs for symptomatic LBP, separated by more than 7 years. The primary outcome of the study was a progression in Pfirrmann score category (I–II, III–IV, V). MRI disc-to-CSF T2 signal-intensity ratio, disc height, disc herniations, high intensity zones (HIZs), and Modic changes were assessed. Results. Baseline and follow-up MRIs were available for 77 discs exposed to PD, and for 260 discs in the matched control cohort. There was no difference in the proportion of punctured discs that advanced in Pfirrmann score category in the PD group (17%, 95% CI 9–27%) compared with corresponding discs in the Control group (21%, 95% CI 17–27%), P = 0.3578, or in non-punctured discs in the PD group (35%, 95% CI 21–51%) compared with corresponding discs in the Control group (34%, 95% CI 27–42%), P = 0.1169. There were no differences in disc-to-CSF T2 signal-intensity ratio, presence of disc herniations, HIZs, or Modic changes following puncture in the PD versus matched cohort discs or in the non-punctured PD cohort discs versus corresponding control cohort discs (P > 0.05). Conclusion. Patients with symptomatic LBP who underwent low-pressure PD, but who did not undergo a subsequent spinal fusion surgery, developed disc degeneration and new disc herniations at a similar rate to corresponding discs in matched control patients. Level of Evidence: 3
Monoclonal gammopathy‐associated thrombotic microangiopathy
Yui, Jennifer , Garceau, Daniel, Jhaveri, Kenar D. , Wanchoo, Rimda, Bijol, Vanesa, Hassoun, Hani , Russell, Stephen J. , Leung, Nelson , Dispenzieri, Angela , Leung, Nelson , Russell, Stephen J , Jhaveri, Kenar D , Glezerman, Ilya G , Dispenzieri, Angela

Mayo Clinic

American Journal of Hematology | July 1, 2019 | Volume: 94 | Issue: 10 | Pages: No page available

10.1002/ajh.25569 | PMID 31257598 Get It